Clinical trial
Auto-immunity and Prognosis of Pulmonary Arterial Hypertension
NCT01208792 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Auto-immunity and Prognosis of Pulmonary Arterial Hypertension
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 15, 2010
- Completion date
- May 15, 2017
- Enrollment
- 629 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
congenital heart defect, connective tissue disease, hiv infection, pulmonary arterial hypertension, systemic sclerosis